Shop

A CBS investigative series reports on different aspects of dangerous medicine. Some of the reports reveal that the managed care has gone out of control. "Health insurance giants ... are harming patients by denying crucial medical care, illegally denying and delaying claims, and using unfair and deceptive trade practices." Insurers also "downcode" doctors' claims - that is, change them to services that pay less or nothing at all. Other stories look at the risks posed by drug studies and the lack of enough oversight from the Food and Drug Administration (FDA). One of the reports tells how a healthy baby died after being enrolled in a study of Propulsid, a heartburn drug that turned out to be dangerous and has been repeatedly rejected by the FDA for pediatric use. The series also examine cases of prescription drugs that should have never been sold, and concludes that FDA has become too close to the pharmaceutical industry. A major finding is that pharmaceutical companies in the U.S. have huge financial incentives to keep dangerous drugs on the market at the cost of patients' deaths and injuries.